News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Gasser Elizabeth Anne
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2023 |
4
| Gasser Elizabeth Anne (EVP, Chief Strategy Officer) has filed a Form 4 on TANDEM DIABETES CARE INC|
Txns:
| Paid exercise price by delivering 57 shares
@ $28.88, valued at
$1.6k
Paid exercise price by delivering 164 shares
@ $28.88, valued at
$4.7k
Exercised 162 options to buy
@ $0
Exercised 474 options to buy
@ $0 |
|
| 05/30/2023 |
4
| Gasser Elizabeth Anne (EVP, Chief Strategy Officer) has filed a Form 4 on TANDEM DIABETES CARE INC|
Txns:
| Paid exercise price by delivering 129 shares
@ $26.57, valued at
$3.4k
Granted 18,037 options to buy
@ $0
Granted 8,883 options to buy
@ $0
Exercised 373 restricted stock units
@ $0 |
|
| 05/17/2023 |
4
| Gasser Elizabeth Anne (EVP, Chief Strategy Officer) has filed a Form 4 on TANDEM DIABETES CARE INC|
Txns:
| Paid exercise price by delivering 57 shares
@ $32.13, valued at
$1.8k
Paid exercise price by delivering 656 shares
@ $32.13, valued at
$21.1k
Exercised 163 restricted stock units
@ $0
Exercised 1,897 restricted stock units
@ $0 |
|
| 03/01/2023 |
4
| Gasser Elizabeth Anne (EVP, Chief Strategy Officer) has filed a Form 4 on TANDEM DIABETES CARE INC|
Txns:
| Paid exercise price by delivering 153 shares
@ $35.87, valued at
$5.5k
Exercised 373 options to buy
@ $0 |
|
| 11/30/2022 |
4
| Gasser Elizabeth Anne (EVP, Chief Strategy Officer) has filed a Form 4 on TANDEM DIABETES CARE INC|
Txns:
| Paid exercise price by delivering 129 shares
@ $39.54, valued at
$5.1k
Exercised 372 options to buy
@ $0 |
|
| 11/17/2022 |
4
| Gasser Elizabeth Anne (EVP, Chief Strategy Officer) has filed a Form 4 on TANDEM DIABETES CARE INC|
Txns:
| Paid exercise price by delivering 57 shares
@ $42.27, valued at
$2.4k
Exercised 163 options to buy
@ $0 |
|
| 08/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2021 |
4
| Gasser Elizabeth Anne (EVP, Chief Strategy Officer) has filed a Form 4 on TANDEM DIABETES CARE INC|
Txns:
| Paid exercise price by delivering 185 shares
@ $129.66, valued at
$24k
Exercised 373 options to buy
@ $0 |
|
| 11/05/2021 |
4
| Gasser Elizabeth Anne (EVP, Chief Strategy Officer) has filed a Form 4 on TANDEM DIABETES CARE INC|
Txns:
| Sold 21,785 shares
@ $140.0233, valued at
$3.1M
Exercised 15,936 options
@ $89.54, valued at
$1.4M
Exercised 4,874 options
@ $82.34, valued at
$401.3k
|
|
| 08/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|